MDM2 and intrahepatic cholangiocarcinoma: Though the deregulation of p53 in ICC is similar to HCC, as there is a loss of cell cycle control and a decrease in apoptotic events, the deregulation in ICC is sometimes more associated with an accumulation of inactive wild-type p53 and its inhibitor mdm-2, rather than a loss of function mutation [113,114].